The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients

Nephrology Dialysis Transplantation

Volumn 31, Issue 6, 2016, Pages 1002-1013

  Massart, Annick ^a,b   Pallier, Annaïck ^c   Pascual, Julio ^d   Viklicky, Ondrej ^e   Budde, Klemens ^f   Spasovski, Goce ^g   Klinger, Marian ^h   Sever, Mehmet Sukru ⁱ   Sørensen, Søren Schwartz ^j   Hadaya, Karine ^k   Oberbauer, Rainer ^l   Dudley, Christopher ^m   De Fijter, Johan W ⁿ   Yussim, Alexander ^o   Hazzan, Marc ^p   Wekerle, Thomas ^q   Berglund, David ^r   De Biase, Consuelo ^s   Pérez Sáez, María José ^d   Mühlfeld, Anja ^t   Orlando, Giuseppe ^u   Clemente, Katia ^v   Lai, Quirino ^v   Pisani, Francesco ^v   Kandus, Aljosa ^w   Baas, Marije ^x   Bemelman, Frederike ^y   Ponikvar, Jadranka Buturovic ^w   Mazouz, Hakim ^z   Stratta, Piero ^aa   Subra, Jean François ^ab   Villemain, Florence ^ab   Hoitsma, Andries ^x   Braun, Laura ^ac   Cantarell, Maria Carmen ^ad   Colak, Hulya ^ae   Courtney, Aisling ^af   Frasca, Giovanni Maria ^ag   Howse, Matthew ^ah   Naesens, Maarten ^ai   Reischig, Tomas ^aj   Serón, Daniel ^ad   Seyahi, Nurhan ⁱ   Tugmen, Cem ^ak   Alonso Hernandez, Angel ^al   Beňa, Luboslav ^am   Biancone, Luigi ^an   Cuna, Vania ^ao   Díaz Corte, Carmen ^ap   Dufay, Alexandre ^aq   Gaasbeek, André ⁿ   Garnier, Arnaud ^ar   Gatault, Philippe ^as   Gentil Govantes, Miguel Angel ^at   Glowacki, François ^p   Gross, Oliver ^au   Hurault De Ligny, Bruno ^av   Huynh Do, Uyen ^aw   Janbon, Bénédicte ^ax   Jiménez Del Cerro, Luis Antonio ^ay   Keller, Frieder ^az   La Manna, Gaetano ^ao   Lauzurica, Ricardo ^ba   Le Monies De Sagazan, Hervé ^aq   Thaiss, Friedrich ^bb   Legendre, Christophe ^bc   Martin, Séverine ^bd   Moal, Marie Christine ^be   Noël, Christian ^p   Pillebout, Evangeline ^bf   Piredda, Gian Benedetto ^bg   Puga, Ana Ramírez ^bh   Sulowicz, Wladyslaw ^bi   Tuglular, Serhan ^bj   Prokopova, Michaela ^e   Chesneau, Mélanie ^bk   Le Moine, Alain ^a   Guérif, Pierrick ^bk   Soulillou, Jean Paul ^c,bk,bl   Abramowicz, Marc ^b   Giral, Magali ^c,bk,bl   Racapé, Judith ^b   Maggiore, Umberto ^s   Brouard, Sophie ^c,bk,bl   Abramowicz, Daniel ^b,bm   more..

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c Department of Research   (France)

^d HOSPITAL DEL MAR   (Spain)

^e INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

^h Nephrology and Transplantation Medicine   (Poland)

ⁱ ISTANBUL UNIVERSITY   (Turkey)

^j Rigshospitalet   (Denmark)

^k GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^l ELISABETHINEN HOSPITAL   (Austria)

^m SOUTHMEAD HOSPITAL   (United Kingdom)

ⁿ LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^o RABIN MEDICAL CENTER   (Israel)

^p LILLE UNIVERSITY HOSPITAL   (France)

^q MEDICAL UNIVERSITY OF VIENNA   (Austria)

^r UPPSALA UNIVERSITY   (Sweden)

^s UNIVERSITY OF PARMA   (Italy)

^t UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^u WAKE FOREST SCHOOL OF MEDICINE   (United States)

^v UOC Trapianti d'Organo   (Italy)

^w UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^x RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^y ACADEMIC MEDICAL CENTER   (Netherlands)

^z AMIENS UNIVERSITY HOSPITAL   (France)

^aa Azienda Ospedaliero Universitaria Maggiore della Carità   (Italy)

^ab ANGERS UNIVERSITY HOSPITAL   (France)

^ac HÔPITAL CIVIL   (France)

^ad HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^ae MH Tepecik Research and Training Hospital   (Turkey)

^af BELFAST CITY HOSPITAL   (United Kingdom)

^ag Azienda Ospedaliera Umberto I   (Italy)

^ah ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^ai UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^aj CHARLES UNIVERSITY   (Czech Republic)

^ak Tepecik Training and Research Hospital   (Turkey)

^al Hospital Universitario   (Spain)

^am L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

^an UNIVERSITY OF TURIN   (Italy)

^ao UNIVERSITY OF BOLOGNA   (Italy)

^ap HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^aq Hopital Victor Provo   (France)

^ar HÔPITAL DES ENFANTS   (France)

^as CHU BRETONNEAU   (France)

^at HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^au UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^av CAEN UNIVERSITY HOSPITAL   (France)

^aw UNIVERSITY OF BERN   (Switzerland)

^ax GRENOBLE UNIVERSITY HOSPITAL   (France)

^ay HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^az UNIVERSITY HOSPITAL ULM   (Germany)

^ba HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^bb UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^bc UNIVERSITÉ PARIS DESCARTES   (France)

^bd Hopital Robert Boulin   (France)

^be BREST UNIVERSITY HOSPITAL   (France)

^bf SAINT LOUIS HOSPITAL   (France)

^bg BROTZU HOSPITAL   (Italy)

^bh HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^bi UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

^bj Nephrology Department   (Turkey)

^bk NANTES UNIVERSITY HOSPITAL   (France)

^bl UNIVERSITÉ DE NANTES   (France)

^bm ANTWERP UNIVERSITY HOSPITAL   (Belgium)

more..

Author keywords

operational tolerance

Indexed keywords

ANTINEOPLASTIC AGENT; AZATHIOPRINE; CHEMOKINE RECEPTOR ANTAGONIST; CREATININE; CYCLOSPORIN; INTERLEUKIN 2 RECEPTOR ANTAGONIST; LYMPHOCYTE ANTIBODY; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID; PREDNISONE; RITUXIMAB; TACROLIMUS; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH CARE FACILITY; HEALTH SURVEY; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KAPOSI SARCOMA; KIDNEY GRAFT; LOW DRUG DOSE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; QUESTIONNAIRE; SKIN CANCER; ALLOTRANSPLANTATION; CLINICAL TRIAL; EUROPE; GRAFT REJECTION; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MULTICENTER STUDY; PROCEDURES; SURVIVAL RATE; TRENDS;

ADULT; EUROPE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; SURVEYS AND QUESTIONNAIRES; SURVIVAL RATE; TRANSPLANT RECIPIENTS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84975113162     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv437     Document Type: Article

References (27)

1. Snyder JJ, Israni AK, Peng Y et al. Rates of first infection following kidney transplant in the United States. Kidney Int 2009; 75: 317-326
2. Farrugia D, Mahboob S, Cheshire J et al. Malignancy-related mortality following kidney transplantation is common. Kidney Int 2014; 85: 1395-1403
3. Ghisdal L, Van Laecke S, Abramowicz MJ et al. New-onset diabetes after renal transplantation: risk assessment and management. Diabetes Care 2012; 35: 181-188
4. Pascual M, Theruvath T, Kawai Tet al. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346: 580-590
5. Scandling JD, Busque S, Dejbakhsh-Jones S et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 2008; 358: 362-368
6. Kawai T, Cosimi AB, Spitzer TR et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353-361
7. Roussey-Kesler G, Giral M, Moreau A et al. Clinical operational tolerance after kidney transplantation. Am J Transplant 2006; 6: 736-746
8. Lerut J, Sanchez-Fueyo A. An appraisal of tolerance in liver transplantation. Am J Transplant 2006; 6: 1774-1780
9. Brouard S, Pallier A, Renaudin K et al. The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases. Am J Transplant 2012; 12: 3296-3307
10. Newell KA, Asare A, Kirk AD et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010; 120: 1836-1847
11. Newell KA. Clinical transplantation tolerance. Semin Immunopathol 2011; 33: 91-104
12. Soulillou JP, Giral M, Brouard S. Operational tolerance in kidney transplantation-improved terminology may enable more precise investigation. Transplantation 2013; 96: e36-e38
13. Starzl TE, Murase N, Demetris AJ et al. Lessons of organ-induced tolerance learned fromhistorical clinical experience. Transplantation 2004; 77: 926-929
14. Zoller KM, Cho SI, Cohen JJ et al. Cessation of immunosuppressive therapy after successful transplantation: a national survey. Kidney Int 1980; 18: 110-114
15. Sagoo P, Perucha E, Sawitzki B et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 2010; 120: 1848-1861
16. Berlanda M, Di Cocco P, Mazzotta C et al. Clinical operational tolerance after kidney transplantation: a short literature review. Transplant Proc 2008; 40: 1847-1851
17. Brouard S, Mansfield E, Braud C et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci USA 2007; 104: 15448-15453
18. Roedder S, Li L, AlonsoMNet al. A three-gene assay formonitoring immune quiescence in kidney transplantation. J Am Soc Nephrol 2015; 26: 2042-2053
19. Baron D, Ramstein G, Chesneau M et al. A common gene signature across multiple studies relate biomarkers and functional regulation in tolerance to renal allograft. Kidney Int 2015; 87: 984-995
20. Girmanova E, Hruba P, Viklicky O. Circulating biomarkers of tolerance. Transplant Rev (Orlando) 2015; 29: 68-72
21. Snanoudj R, Tinel C, Legendre C. Immunological risks of minimization strategies. Transpl Int 2015; 28: 901-910
22. Ballet C, Roussey-Kesler G, Aubin JT et al. Humoral and cellular responses to influenza vaccination in human recipients naturally tolerant to a kidney allograft. Am J Transplant 2006; 6: 2796-2801
23. http://www.ctstransplant.org/public/policy.shtml, K-15102 and K-15107, 17 April 2015, date last accessed
24. Baron D, Giral M, Brouard S. Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes. Transpl Int 2015; 28: 938-959
25. Devuyst O, Knoers NV, Remuzzi G et al. Rare inherited kidney diseases: challenges, opportunities, and perspectives. Lancet 2014; 383: 1844-1859
26. Kelly RJ, Hochsmann B, Szer J et al. Eculizumab in pregnant patients with paroxysmal nocturnal hemoglobinuria.NEngl J Med 2015; 373: 1032-1039
27. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953; 172: 603-606